Previous 10 | Next 10 |
HanesBrands (NYSE:HBI), the world’s largest supplier of collegiate fan apparel, announces a five-year extension of its current partnership with TCU, renewing the exclusive rights to manufacture and sell Horned Frog fanwear in the mass retail channel. This press release features multime...
2024-05-14 13:50:21 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some deep-value investors don’t mind picking up extremely battered stocks that may have seen their intrinsic value swing to the downside. So, it makes sense to look at some plays now tra...
2024-05-09 11:56:56 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hanesbrands (NYSE: HBI ) just reported results for the first quarter of 2024. Hanesbrands reported earnings per share of -2 cents. This was above the analyst estimate for ...
2024-05-09 11:03:10 ET Hanesbrands Inc. (HBI) Q1 2024 Earnings Conference Call May 09, 2024, 08:30 AM ET Company Participants T.C. Robillard - Vice President of Investor Relations Stephen Bratspies - Chief Executive Officer Scott Lewis - Chief Financial Officer ...
2024-05-09 07:05:29 ET More on Hanesbrands Hanesbrands: Not An Opportunity Even After The Recent Drop What Hanesbrands Inc. Could Look Like With And Without Champion Hanesbrands: Looks To Unlock Value Via Champion Sale Hanesbrands Q1 2024 Earnings Preview ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Net sales were $1.16 billion, the midpoint of the Company’s expected range. GAAP and Adjusted gross margin of 39.9% increased 750 and 720 basis points, respectively, compared to prior year, ahead of expectations. GAAP operating profit was $52 million. Adjusted operating pro...
2024-05-08 12:31:39 ET More on Hanesbrands Hanesbrands: Not An Opportunity Even After The Recent Drop What Hanesbrands Inc. Could Look Like With And Without Champion Hanesbrands: Looks To Unlock Value Via Champion Sale Hanesbrands and Duke University extend f...
HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. Jim Green, Chairman and CEO, said, “As expected, our first quarter revenues reflect o...
HanesBrands (NYSE: HBI) today provided details for its first-quarter 2024 investor conference call at 8:30 a.m. ET Thursday, May 9, 2024. Prior to the conference call that day, HanesBrands will issue a news release disclosing financial results for the quarter ended March 30, 2023. Confe...
News, Short Squeeze, Breakout and More Instantly...
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
2024-06-05 19:15:02 ET UBS analyst issues NEUTRAL recommendation for HBI on June 5, 2024 05:20PM ET. The previous analyst recommendation was Neutral. HBI was trading at $5.3 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst...
Transaction Valued at $1.2 Billion With Potential to Achieve $1.5 Billion Based on Contingent Cash Consideration of up to $300 Million Increased Focus on Global Innerwear Business and Accelerated Debt Paydown Further Positions Company to Deliver Enhanced Value for Shareholders H...